` Comparison: NPCE vs ABT - Alpha Spread

NPCE
vs
ABT

Over the past 12 months, NPCE has significantly outperformed ABT, delivering a return of +6% compared to the ABT's 16% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NPCE
ABT
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NPCE Intrinsic Value
HIDDEN
Show
ABT Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Neuropace Inc
NASDAQ:NPCE
14.655 USD
Abbott Laboratories
NYSE:ABT
114.57 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NPCE, ABT

NPCE
ABT
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Neuropace Inc
Revenue
Abbott Laboratories
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
NPCE, ABT

NPCE
ABT
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Neuropace Inc
NASDAQ:NPCE
Abbott Laboratories
NYSE:ABT
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

NPCE
76.8%
ABT
56.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Neuropace Inc
Abbott Laboratories

Operating Margin

NPCE
-19.7%
ABT
19.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Neuropace Inc
Abbott Laboratories

Net Margin

NPCE
-25.3%
ABT
14.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Neuropace Inc
Abbott Laboratories

FCF Margin

NPCE
-17.5%
ABT
15.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Neuropace Inc
Abbott Laboratories

ROE

NPCE
-169.3%
ABT
13.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Neuropace Inc
Abbott Laboratories

ROA

NPCE
-23.6%
ABT
7.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Neuropace Inc
Abbott Laboratories

ROIC

NPCE
-46.8%
ABT
9.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Neuropace Inc
Abbott Laboratories

ROCE

NPCE
-22.1%
ABT
12.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Neuropace Inc
Abbott Laboratories

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
NPCE, ABT

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NPCE, ABT

Performance Gap Between NPCE and ABT
HIDDEN
Show

Performance By Year
NPCE, ABT

Loading
NPCE
ABT
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NPCE to other stocks
ISRG
Intuitive Surgical Inc
SYK
Stryker Corp
MDT
Medtronic PLC
BSX
Boston Scientific Corp
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account